SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTION IN ADOLESCENTS AND CHILDREN AGED 3 TO 17 YEARS OLD THROUGH 24 WEEKS POST-TREATMENT Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Sokal, Etienne; Schwarz, Kathleen B.; Rosenthal, Philip; Verucchi, Gabriella; Lin, Chuan-Hao; Balistreri, William; Wen, Jessica; Whitworth, Suzanne; Leung, Daniel H.; Bansal, Sanjay; Karnsakul, Wikrom; Mangia, Alessandra; Rao, Girish S.; Shao, Jiang; Hsueh, Chia-Hsiang; Parhy, Bandita; Gaggar, Anuj; Kersey, Kathryn; Narkewicz, Michael R.; Gonzalez-Peralta, Regino P.; Murray, Karen F.; Romero, Rene; Jonas, Maureen M.

authors

Publication Date

  • November 1, 2020

webpage

published in

category

start page

  • 570A

end page

  • 570A

volume

  • 72